The Efficacy of a Tart Cherry Drink for the Treatment of Patellofemoral Pain in Recreational Athletes.
1 other identifier
interventional
24
1 country
1
Brief Summary
Patellofemoral pain (PFP) is the most common chronic pathology in sports medicine and physiotherapy clinics. As pain and inflammation are the main symptoms of PFP, non-steroidal anti-inflammatory and analgesic medications are often utilized to decrease pain and inflammation; however alternative treatments are increasingly being sought due to the cardiovascular and gastrointestinal side effects of traditional pain medications. Most researchers advocate conservative treatment, though there is still insufficient clarity regarding the effectiveness of conservative treatment modalities. Dietary interventions for PFP have not received any attention in clinical literature, yet there is a growing body of evidence indicating that cherries have significant anti-inflammatory, antioxidant and pain-mediating effects. Therefore, the primary purpose of the proposed investigation was to test (using a randomized control investigation) the ability of a tart cherry juice blend to provide symptom relief in recreational athletes with PFP and to understand the biological and mechanical mechanisms behind any changes in PFP symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2018
CompletedFirst Posted
Study publicly available on registry
November 16, 2018
CompletedStudy Start
First participant enrolled
May 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedJuly 21, 2020
May 1, 2019
1 year
November 10, 2018
July 20, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Knee injury and Osteoarthritis Outcome Score (KOOS) - patellofemoral scale
This is a questionnaire based measurement that allows participants to subjectively rate the extent of their patellofemoral pain symptoms. This measurement is scored on a 0-100 scale with 100 indicating no pain.
6-weeks
Secondary Outcomes (6)
COOP-WONCA - psychological wellbeing
6-weeks
Plasma urate
6-weeks
Creatinine
6-weeks
human TNF-alpha
6-weeks
High sensitivity C-reactive protein
6-weeks
- +1 more secondary outcomes
Study Arms (2)
Placebo
PLACEBO COMPARATORCherry juice
EXPERIMENTALInterventions
30 mL of tart cherry juice concentrate, which will be diluted with 200 mL of water.
Identical in taste and colour to the Cherry juice, but with no anthocyanin content
Eligibility Criteria
You may qualify if:
- Recreationally active
- Suffering from mild to moderate patellofemoral pain with no evidence of any other condition.
You may not qualify if:
- Rheumatoid arthritis or other systemic inflammatory condition
- Chronic pain syndrome
- Corticosteroid medication in last 2 months (intra-articular or oral)
- Intra-articular injections of hyaluronic acid in the last 9 months
- Pregnancy
- Diabetes
- Food allergies to cherries.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Central Lancashire
Preston, Lancs, PR1 2HE, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Lecturer
Study Record Dates
First Submitted
November 10, 2018
First Posted
November 16, 2018
Study Start
May 30, 2019
Primary Completion
May 30, 2020
Study Completion
June 1, 2020
Last Updated
July 21, 2020
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share